Search for: "J. E. F." Results 5321 - 5340 of 6,244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Editor’s Note: Eduardo Gallardo is a partner focusing on mergers and acquisitions at Gibson, Dunn & Crutcher LLP. [read post]
30 Jan 2010, 4:37 pm by Bill Marler
HAV is relatively stable and can survive for several hours on fingertips and hands and up to two months on dry surfaces, but can be inactivated by heating to 185°F (85°C) or higher for one minute or disinfecting surfaces with a 1:100 dilution of sodium hypochlorite (household bleach) in tap water (Advisory Committee on Immunization Practices [ACIP], 2006; CDC, 2009c; Todd et al., 2009). [read post]
29 Jan 2010, 9:42 am by dnt.atheniense@gmail.com
"Além da celeridade processual, da redução de custos e do impacto ambiental em razão da desnecessidade de uso de papel, o e-STF vai gerar um choque de acessibilidade, já que todos terão acesso aos processos que tramitam na Suprema Corte. [read post]
28 Jan 2010, 5:00 am by dnt.atheniense@gmail.com
Há ainda a possibilidade da criação de WebService, entre os bancos e o Poder Judiciário, para uma integração mais fácil e rápida dos processos eletrônicos. [read post]
28 Jan 2010, 4:51 am by Jonathan Rosenfeld
John’s Wort can reduce the concentration of medications in the blood; Vitamin E can increase anti-clotting activity and cause increased risk of bleeding when taken with blood-thinning medication; Ginseng can enhance the bleeding effects of aspirin and ibuprofen; and Ginkgo Biloba can decrease the effectiveness of anticonvulsant therapy. [read post]
24 Jan 2010, 9:40 am
Your promotion and introduction into interstate commerce of the BioFind III (or Biofind), BioPack II (or BioPack), Light Patch, Spinal Pad, and the Knee Saver for these uncleared indications render them adulterated under section 501 (f)(1)(B) of the Act, for failure to obtain FDA premarket approval, and misbranded under section 502(o) of the Act, for failure to notify the agency of your intent to introduce the device into commercial distribution, as required by section… [read post]
24 Jan 2010, 9:40 am
Your promotion and introduction into interstate commerce of the BioFind III (or Biofind), BioPack II (or BioPack), Light Patch, Spinal Pad, and the Knee Saver for these uncleared indications render them adulterated under section 501 (f)(1)(B) of the Act, for failure to obtain FDA premarket approval, and misbranded under section 502(o) of the Act, for failure to notify the agency of your intent to introduce the device into commercial distribution, as required by section… [read post]
23 Jan 2010, 6:53 pm by admin
The following is a summary review of articles from all over the nation concerning environmental law settlements, decisions, regulatory actions and lawsuits filed during the past week. [read post]
23 Jan 2010, 6:32 am by Katherine Scanlon
The Receiver will supply each potential purchaser who is given access to the Remaining Portfolio, with a form on which to submit its written bid substantially in the format set forth in Exhibit 2 to Dkt. 1823; e) Upon receipt of the last bid prior to the bid deadline, the Receiver and the Examiner will rank the bids according to the amounts thereof and f) Assuming the highest bid is acceptable to the Receiver, a Purchase and Sale Agreement (in substantially the form attached as… [read post]
22 Jan 2010, 9:00 am by dnt.atheniense@gmail.com
"No portal do contribuinte, o cidadão já pode tirar certidão negativa, imprimir o Darf, fazer o pagamento e consultar a malha fina. [read post]
18 Jan 2010, 4:31 pm
  La apertura del legislador español hacia las nuevas tecnologías de la información se inició hace más de quince años. [read post]
16 Jan 2010, 10:12 pm by Salcido
(f) Physical Education (1.0 units of credit); (g) Health Education (0.5 units of credit); (h) Career and Technical Education, Life, and Careers (1.0 units of credit); (i) Educational Technology (credit optional); (j) Library Media (integrated into subject areas). [read post]
15 Jan 2010, 7:55 am by Bill Marler
Given that there are other bugs, namely Enterohemorrhagic Non-E. coli O157:H7, that cause human illness and death, I petitioned the FSIS to deem these pathogens as adulterants. [read post]
14 Jan 2010, 9:00 pm by Dr. Mark Lee Levine
Although Code §1031 has existed for many decades, there have also been a number of interesting issues to construe and interpret in the application of tax-deferred exchanges under Code §1031. [read post]
13 Jan 2010, 12:49 pm by Adam Thierer
by Adam Thierer & Berin Szoka, Progress Snaphot 6.1 Stephanie Clifford of the New York Times posted a very interesting article this week summarizing a recent “on-the-record chat” the Times staff had with Federal Trade Commission (FTC) chairman Jon Leibowitz and FTC Bureau of Consumer Protection chief David Vladeck. [read post]
9 Jan 2010, 11:03 pm by Eugene Volokh
Rocky Mountain Motor Tariff Bureau, Inc., 690 F.2d 1240 (9th Cir. 1982). [read post]